You are here

  • Home
  • Archive
  • Volume 82, Issue 6
  • Correspondence on: ‘What comes after the lockdown? Clustering of ANCA-associated vasculitis: single-centre observation of a spatiotemporal pattern’

Article Text

Article menu
Download PDFPDF
Correspondence
Correspondence on: ‘What comes after the lockdown? Clustering of ANCA-associated vasculitis: single-centre observation of a spatiotemporal pattern’
  1. Alojzija Hočevar1,2,
  2. Aleš Ambrožič1,
  3. Matija Tomšič1,2
  1. 1 Department of Rheumatology, University Medical Centre Ljubljana Division of Internal Medicine, Ljubljana, Slovenia
  2. 2 Internal Medicine, University of Ljubljana Faculty of Medicine, Ljubljana, Slovenia
  1. Correspondence to Dr Alojzija Hočevar, Department of Rheumatology, University Medical Centre Ljubljana Division of Internal Medicine, Ljubljana 1000, Slovenia; alojzija.hocevar{at}gmail.com

https://doi.org/10.1136/annrheumdis-2021-220290

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    It was with great interest that we read the article by Gauckler et al titled ‘What comes after the lockdown? Clustering of ANCA-associated vasculitis: single-centre observation of a spatiotemporal pattern’, published in Ann Rheum Dis in December 2020.1 Its authors reported a twofold increase of the incidence rate of antineutrophil cytoplasmic antibodies (ANCA)-associated vasculitis (AAV) diagnoses and a threefold increase in incidence rate of de novo AAV manifestations at their centre compared with previous years. Furthermore, they found the clustering of cases following the end of the pandemic’s first wave. The increase in the incidence could not be attributed to a deferral of symptoms or delayed diagnoses.

    Indeed, the SARS-CoV-2 virus pandemic significantly affected our daily rheumatological routine and the management of systemic vasculitides. We had to adjust our daily practice practically overnight, …

    View Full Text

    Footnotes

    • Contributors AH contributed to the acquisition, analysis and interpretation of data. AA and MT helped to revise the manuscript. All authors have read and approved the manuscript for submission.

    • Funding The study was funded by the Slovenian Research Agency - research core funding P3-0314.

    • Competing interests None declared.

    • Provenance and peer review Not commissioned; internally peer reviewed.

    • Supplemental material This content has been supplied by the author(s). It has not been vetted by BMJ Publishing Group Limited (BMJ) and may not have been peer-reviewed. Any opinions or recommendations discussed are solely those of the author(s) and are not endorsed by BMJ. BMJ disclaims all liability and responsibility arising from any reliance placed on the content. Where the content includes any translated material, BMJ does not warrant the accuracy and reliability of the translations (including but not limited to local regulations, clinical guidelines, terminology, drug names and drug dosages), and is not responsible for any error and/or omissions arising from translation and adaptation or otherwise.

    Linked Articles